Status:

COMPLETED

Motion Analysis of EMP Knee Versus Posterior Stabilized Knee Arthroplasty for Osteoarthritis

Lead Sponsor:

Ottawa Hospital Research Institute

Collaborating Sponsors:

Stryker Trauma and Extremities

Conditions:

Arthropathy of Knee Joint

Eligibility:

All Genders

50-75 years

Phase:

NA

Brief Summary

The purpose of the current study is to analyze and compare the lower-limb joint motions and muscle activation patterns during activities of daily living as well as self reported health related functio...

Detailed Description

Inclusion: 40 patients between the ages of 50 and 75 yrs undergoing unilateral total knee replacement for non-inflammatory degenerative osteoarthritis will participate, as well as 10 control particip...

Eligibility Criteria

Inclusion

  • 40 patients between the ages of 50 and 75 yrs undergoing unilateral total knee replacement for non-inflammatory degenerative osteoarthritis will participate, as well as 10 control participants will be recruited from the general population for the present study matching to experimental groups for age, gender and BMI.Patients who do not meet any exclusion criteria.

Exclusion

  • Potential participants for the control group will be asked if they have had degenerative osteoarthritis of lower-limb joints (hip, knee and ankle) and if they have they will be excluded.
  • Exclusion for patient group
  • Patients suffering from any other lower-limb joint disorders other than the one for which total knee arthroplasty.
  • Patients with any other joint replacement in the ipsilateral and contralateral limb.
  • Patients with evidence of active infection.
  • Patients with neurologic or musculoskeletal disease that may adversely affect gait, weight-bearing or quadriceps function.
  • Patients with neuropathic joints.
  • Patients requiring structural bone grafts.
  • Patients with a documented allergy to cobalt chromium molybdenum.
  • Patient with a BMI larger than 30 kg/m2.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00967161

Start Date

January 1 2012

End Date

June 1 2015

Last Update

November 18 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ottawa General Hospital

Ottawa, Ontario, Canada, k1Y 4E9